Non-invasive energy upconversion methods and systems

Patent metadata

Field	Value
Publication number	US-11324965-B2
Application number	US-201916511536-A
Country	US
Kind code	B2
Filing date	Jul 15, 2019
Priority date	Apr 21, 2009
Publication date	May 10, 2022
Grant date	May 10, 2022

Abstract

Products, compositions, systems, and methods for modifying a target structure which mediates or is associated with a biological activity, including treatment of conditions, disorders, or diseases mediated by or associated with a target structure, such as a virus, cell, subcellular structure or extracellular structure. The methods may be performed in situ in a non-invasive manner by placing a nanoparticle having a metallic shell on at least a fraction of a surface in a vicinity of a target structure in a subject and applying an initiation energy to a subject thus producing an effect on or change to the target structure directly or via a modulation agent. The nanoparticle is configured, upon exposure to a first wavelength λ1, to generate a second wavelength λ2 of radiation having a higher energy than the first wavelength λ1. The methods may further be performed by application of an initiation energy to a subject in situ to activate a pharmaceutical agent directly or via an energy modulation agent, optionally in the presence of one or more plasmonics active agents, thus producing an effect on or change to the target structure. Kits containing products or compositions formulated or configured and systems for use in practicing these methods.

First claim

The invention claimed is:

1. A method for modifying a target structure which mediates or is associated with a biological activity, comprising:
placing in a vicinity of a target structure in a subject in need of treatment an agent receptive to microwave radiation or radiofrequency radiation; and
applying as an initiation energy said microwave radiation or radiofrequency radiation by which the agent directly or indirectly generates emitted light in the infrared, visible, or ultraviolet range, wherein the emitted light contacts the target structure and induces a predetermined change in said target structure in situ,
wherein said predetermined change modifies the target structure and modulates the biological activity of the target structure.

2. The method of claim 1 , wherein placing an agent comprises placing a nanoparticle including a metallic structure in relation to the nanoparticle.

3. The method of claim 2 , wherein placing the nanoparticle comprises placing a nanoparticle having a dielectric core.

4. The method of claim 3 , wherein placing the nanoparticle comprises at least one of:
placing a nanoparticle having a metallic shell including at least one of a spherical shell, an oblate shell, a crescent shell, a multilayer shell, or an array of metal nanoislands on the surface of the core nanoparticle in the vicinity of the target structure;
placing a nanoparticle having an array of metal nanoislands on the surface of the core nanoparticle in the vicinity of the target structure; or
placing a nanoparticle having an array of nanoislands on the surface of the core nanoparticle in the vicinity of the target structure.

5. The method of claim 3 , wherein the nanoparticle comprises a metallic structure comprising at least one of element selected from the group consisting of Au, Ag, Cu, Ni, Pt, Pd, Co, Ru, Rh, Al, Ga, and a combination thereof.

6. The method of claim 3 , wherein the nanoparticle comprises a core comprising least one compound selected from the group consisting of Y 2 O 3 , Y 2 O 2 S, NaYF 4 , YAG, YAP, Nd 2 O 3 , LaF 3 , LaCl 3 , La 2 O 3 , TiO 2 , LuPO 4 , YVO 4 , YbF 3 , YF 3 , Na-doped YbF 3 , SiO 2 and alloys or layers thereof.

7. The method of claim 3 , wherein the nanoparticle comprises a dopant comprising at least one of element selected from the group consisting of Er, Eu, Yb, Tm, Nd, Tb, Ce, Y, U, Pr, La, Gd, other rare-earth species and a combination thereof.

8. The method of claim 1 , wherein placing an agent comprises placing at least one of a phosphorescent molecule, a fluorescent molecule, or a luminescent inorganic molecule, each displaying emission upon exposure to said microwave radiation or radiofrequency radiation.

9. The method of claim 1 , wherein placing an agent comprises placing at least one of a chemiluminescent molecule, displaying emission upon exposure to said microwave radiation or radiofrequency radiation.

Assignees

• Immunolight Llc
• Univ Duke
• Immunoloight Llc

Inventors

• Vo-Dinh Tuan
• Scaffidi Jonathan P
• Chada Venkata Gopal Reddy
• Lauly Benoit
• Zhang Yan
• Gregas Molly K
• Stanton Ian Nicholas
• Stecher Joshua T
• Therien Michael J
• Bourke Jr Frederic A
• Walder Harold
• Fathi Zak
• Ayres Jennifer A
• Zhang Zhenyuan
• Simmons Joseph H
• Norton Stephen John

Classifications

• A61L2103/09

  Blood or products thereof · CPC title

• A61L2/10

  Ultraviolet [UV] radiation · CPC title

• A61L2103/05

  Living organisms or biological materials · CPC title

• A61P35/00

  Antineoplastic agents · CPC title

• A61P33/00

  Antiparasitic agents · CPC title